SGFG
GMAB icon

Silver Grove Financial Group’s Genmab GMAB Stock Holding History

Silver Grove Financial Group’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.23K Buy
+154
New +$4.09K ﹤0.01% 1274

Other funds holding GMAB

PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Silver Grove Financial Group's GMAB Position: Q2 2026 in Review

Silver Grove Financial Group opened a new position in Genmab (GMAB) in Q2 2026: 154 shares worth $4.23K. The stake represents ﹤0.01% of the portfolio and ranks #1274 among its holdings.

290 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • Silver Grove Financial Group held 154 shares of Genmab worth $4.23K as of Q2 2026.
  • Genmab was a new Silver Grove Financial Group position in Q2 2026.
  • Genmab made up ﹤0.01% of Silver Grove Financial Group's portfolio in Q2 2026, its #1274 holding.
  • 290 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on Silver Grove Financial Group's 13F filing for Q2 2026, filed 13 Aug 2026.